Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

• Status: Recruiting
• Trial end date: 2023-05-01

Summary

To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment

• Phase: Phase 2

Details

• Lead Sponsor: Samsung Medical Center
• Treatments: Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Etoposide phosphate; Ifosfamide; Isophosphamide mustard; Liposomal doxorubicin; Melphalan; Thiotepa